-+ 0.00%
-+ 0.00%
-+ 0.00%
According to the enterprise research app, recently, Shenzhen Blue Satin Biotechnology Co., Ltd. was established. The legal representative is Jin Chunlei, with a registered capital of about 281 million yuan. The business scope includes medical research and experimental development; technology import and export. Enterprise investigation and equity penetration shows that the company is jointly owned by Dongyang Pharmaceutical and Bingzhoushi Biotechnology Co., Ltd.
Share
Listen to the news
According to the enterprise research app, recently, Shenzhen Blue Satin Biotechnology Co., Ltd. was established. The legal representative is Jin Chunlei, with a registered capital of about 281 million yuan. The business scope includes medical research and experimental development; technology import and export. Enterprise investigation and equity penetration shows that the company is jointly owned by Dongyang Pharmaceutical and Bingzhoushi Biotechnology Co., Ltd.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending